During the last session, Mind Medicine Inc (NASDAQ:MNMD)’s traded shares were 4.7 million, with the beta value of the company hitting 1.75. At the end of the trading day, the stock’s price was $8.65, reflecting an intraday gain of 1.65% or $0.14. The 52-week high for the MNMD share is $12.22, that puts it down -41.27 from that peak though still a striking 49.71% gain since the share price plummeted to a 52-week low of $4.35. The company’s market capitalization is $634.32M, and the average trade volume was 1.68 million shares over the past three months.
Mind Medicine Inc (MNMD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.10. MNMD has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.28.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Mind Medicine Inc (MNMD) registered a 1.65% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.65% in intraday trading to $8.65, hitting a weekly high. The stock’s 5-day price performance is -3.57%, and it has moved by 35.26% in 30 days. Based on these gigs, the overall price performance for the year is 81.34%.
The consensus price target of analysts on Wall Street is $14, which implies an increase of 38.21% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $14 and $14 respectively. As a result, MNMD is trading at a discount of -61.85% off the target high and -61.85% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 2.29%. While earnings are projected to return 41.32% in 2025, the next five years will return 14.93% per annum.
MNMD Dividends
Mind Medicine Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
